Boehringer Ingelheim and Cue Biopharma, Inc. (Nasdaq: CUE) today announced a strategic research collaboration and license agreement to develop and commercialize Cue Biopharma’s CUE-501 product ...

Six rising stars at Scotland's largest vaccine manufacturer, Valneva Scotland, have embarked on an emerging leaders programme, equipping them with skills for life and helping unlock their full ...